BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 13, 2013
View Archived Issues
Identification of a plasma biomarker to assess resistant GVHD
Read More
Novel M4 receptor modulators presented by The Vanderbilt University
Read More
Amicus Therapeutics collaborates with Biogen Idec for Parkinson's disease drugs
Read More
Eliglustat noninferior to imiglucerase in phase III ENCORE study
Read More
Phase IIb AllerT birch pollen allergy vaccine study meets primary endpoint
Read More
SMT-19969 shows selective activity against C. difficile infection
Read More
Antisense oligonucleotides synergistically inhibit prostate cancer cell growth in vitro and in vivo
Read More
Amgen presents novel GPR119 agonists at ACS meeting
Read More
Dainippon Sumitomo Pharma reports discovery of glucagon receptor antagonists
Read More
Kakeromycin may represent a new class of antifungals
Read More
Wayne State University discloses new gene constructs for cancer
Read More
First patient treated in Neuralstem's phase II trial in ALS
Read More
Roche acquires license to Inovio's DNA-based prostate cancer and hepatitis B vaccine candidates
Read More
ChemoCentryx reports interim data for CCX-140 in patients with diabetic nephropathy
Read More
Actelion to initiate phase III program of cadazolid for CDAD
Read More
FCGR3A gene and its association with sarcoidosis
Read More
RedHill Biopharma's RHB-104 shows potential for treatment of lupus
Read More
ALS Therapy Development Institute and Anida Pharma form partnership
Read More
Theraclone Sciences begins phase IIa trial of TCN-202 for prevention of CMV
Read More
FDA grants breakthrough therapy designation to entinostat in advanced breast cancer
Read More
Janssen Biotech initiates phase II study of daratumumab in multiple myeloma
Read More
Dosing begins in phase II trial of Conatus' emricasan in severe alcoholic hepatitis
Read More
Verastem commences phase II trial of defactinib in mesothelioma
Read More
Exelixis begins CELESTIAL phase III trial of cabozantinib
Read More
Italian group discloses novel GSK-3 beta inhibitors
Read More
FDA committee recommends accelerated approval of new indication for Genentech's Perjeta
Read More
FDA grants fast track designation to Synta's ganetespib in non-small cell lung adenocarcinoma
Read More
Sanofi withdraws lixisenatide NDA in the U.S.
Read More